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Background: The use of lipid soluble opioids such as fentanyl, alfentanil and sufentanil are recently on the increase 
for patient-controlled epidural analgesia (PCEA). In this study, the effects and adequate dose of sufentanil in 
arthroplasty were investigated.
Methods: Eighty patients scheduled for arthroplasty were enrolled for the study. Seventy-one patients (ASA physical 
status I-III) were randomly allocated into four groups. All groups received 0.1% ropivacaine through PCEA and each 
group received either fentanyl (group F: fentanyl 4 μg/ml) or sufentanil (group S1: sufentanil 0.5 μg/ml, group S2: 
sufentanil 0.75 μg/ml, and group S3: sufentanil 1.0 μg/ml). Postoperative pain scores were evaluated using VAS (visual 
analog scale, 0-10) and side effects such as hypotension, nausea/vomiting, pruritus and the degree of satisfaction 
were evaluated at 1, 6, 12, 24, 48 hours after surgery.
Results: Postoperative pain score (VAS) decreased gradually and the highest VAS score was recorded at 1 hour 
postoperative for all four groups. There were no differences in the degree of satisfaction and postoperative pain score 
between all groups. The incidence of pruritus was significantly lower in group S1 than in groups S2 and S3.
Conclusions: The incidence of side effects were significantly lower in group S1 (0.1% ropivacaine plus sufentanil 0.5   
μg/ml). Therefore, 0.5  μg/ml of sufentanil through PCEA is the recommended dose for postoperative pain control in 
arthroplasty. (Korean J Anesthesiol 2011; 60: 41-46)
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Introduction
    Hip or knee replacement arthroplasty are common in many 
elderly patients, and these surgeries are considerably more 
painful than other orthopedic surgeries. The pain can cause 
immense suffering to the patient, and also alter physiological 
functions induced by hormonal changes due to sympathetic 
nervous system activation. Cardiac function and vessel elasticity 
are decreased in the elderly, so the increase of sympathetic 
nervous system activity can stress the heart due to high blood 
pre  ssure and/or rapid heart rate. This can increase the risk of 
myocar  diac ischemia or infarction because the myocardiac 
oxygen demand exceeds its supply [1]. For this reason, early 
postoperative pain control should improve the outcome of surgery.
    Patient-controlled epidural analgesia (PCEA) provides better 
results than intravenous pain control in orthopedic lower limb 
surgery [1]. Local anesthetics combined with opioids have 
been used in PCEA since opioids reduce the minimum local 
analgesic concentration (MLAC) of local anesthetics [2] and this 
dose-dependent effect of opioids can prevent local anesthetic-
induced postural hypotension and enable early ambulation 
[1,3]. Since lipophilic sufentanil appears to have a greater 
antinociceptive effect than hydrophilic morphine, a small dose 
of sufentanil is effective for pain control [4]. In addition, side 
effects such as pruritus and sedation are low [5] and sufentanil 
blocks μ-receptor more selectively than fentanyl [1]. For the 
reason, it has been suggested that sufentanil has increased 
analgesic effects and fewer side effects than fentanyl. However, 
no study has evaluated the comparative analgesic effects of 
these two drugs in orthopedic lower limb surgery. 
    In this study, we performed a prospective, randomized 
study in patients undergoing arthroplasty to compare the 
effectiveness on pain and the incidence of side effects of 
the following two drugs: sufentanil-ropivacaine or fentanyl-
ropivacaine through PCEA. Secondly, we evaluated the optimal 
dose of epidural sufentanil. 
Materials and Methods
    The prospective study was performed after approval by the 
committee on Human Research. Eighty patients which were 
classified by the American society of anesthesiologists as 
status (ASA) I-III were scheduled for total knee replacement 
arthroplasty (TKRA), total hip replacement arthroplasty (THRA) 
and bipolar hemiarthroplasty. Exclusion criteria included 
a history of drug allergy and psychiatric disease, an 80 year 
patient age limit and contraindications to epidural anesthesia 
(preoperative coagulopathy and localized infection). All 
operations were performed by a single orthopedic surgeon. 
    As previous studies calculated the sample size based on 20% 
to 33% decrease in pain score [6-9], we calculated that a mean 
difference in VAS between groups of 30%, with reduced pain 
scores in the sufentanil group, would permit a type 1 error 
rate of one-tailed α = 0.05 and a type 2 error of β = 0.20. This 
analysis indicated that a sample size of 17 patients per group 
was essential. Nine patients were not included in this study for 
the following reasons; injection of analgesics immediately after 
surgery on ward in 5 patients, spontaneous epidural catheter 
removal in 3 patients, and error of PCA pump in 1 patient.
    After routine monitors were placed in the operating room, 
catheters were inserted at the L3-4 or L4-5 interspace. We 
identified the epidural space using the loss of resistance (LOR) 
method and inserted a catheter of 4-10 cm to the cephalad 
from the skin. All catheters were tested for intravascular or 
subarachnoid placement with 3 ml of 2% lidocaine containing 
1 : 200,000 epinephrine. All epidural catheter insertions were 
performed by an experienced anesthesiologist.
    General anesthesia was induced after epidural catheter 
insertion with 1.5 mg/kg propofol and 0.5-1.0 μg/kg fentanyl. 
Tracheal intubation was facilitated by 0.6 mg/kg rocuronium. 
All patients underwent mechanical ventilation with an 
equal mixture of oxygen and nitrous oxide. Anesthesia was 
maintained with 100-200 μg/kg/min propofol.
    Seventy-one patients were randomly allocated into four 
groups. All groups received 250 ml of 0.1% ropivacaine through 
a PCEA pump (Ambix anaplus
Ⓡ, E-Wha Fresenius Kabi, Korea) 
and each group received either fentayl (group F: fentanyl 4 μg/
ml) or sufentanil (group S1: sufentanil 0.5 μg/ml, group S2: 
sufentanil 0.75 μg/ml, and group S3: sufentanil 1.0 μg/ml). 
Epidural analgesia began 30 min before the end of surgery. The 
PCEA pump was programmed to deliver a 2 ml bolus with a 
lockout interval of 12 min and background infusion of 4 ml/h. 
    An anesthesiologist that was unaware of the group assignment 
evaluated the postoperative pain score, incidence of side effects 
(such as hypotension, nausea/vomiting, pruritus, headache, 
sedation, respiratory depression and numbness) and degree of 
satisfaction for PCEA on 1, 6, 12, 24, 48 hours following surgery. The 
pain score was evaluated using VAS (visual analogue scale, 0-10).
    Hypotension was defined when systolic arterial blood pressure 
decreased to less than 90 mmHg or mean arterial pressure 
decreased to a level of 20% above baseline following which 
the patient received ephedrine 8 mg intravenously. When the 
patient complained of nausea or vomiting, IV ondansetron 4 
mg IV was administrated and for respiratory depression, IV 
naloxone 200 μg IV was administrated. 
    The overall satisfaction score according to PCEA was recorded 
using a 4-point categorical scale (very good, good, fair, and 
poor) 48 hours after surgery. The duration of the operation, 
duration of anesthesia and level of blood loss was recorded.
    Data was collected and analyzed using SPSS v 14.0k (SPSS 43 www.ekja.org
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inc., Chicago, USA). All variables are presented as means 
± the standard deviation (SD). Continuous variables were 
analyzed using one way ANOVA after the Komogorov-Smirnov 
or Kruskal-Wallis test. The difference of the pain score among 
groups was calculated using the Kruskal-Wallis test. Categorical 
values were analyzed with the chi-square test or Fisher's exact 
test. A P value < 0.05 was considered significant.
Results
    All groups of patients were similar with respect to demo-
graphic and anesthetic data (Table 1). Postoperative pain 
score (VAS) decreased gradually according to time. However, 
pain control was successful in every group. Also, there was no 
significant difference of VAS in each group (Fig. 1). Nausea 
and vomiting were the most common side effects (n = 23) and 
pruritus (n = 15), numbness (n = 14), headache (n = 13) and 
sedation (n = 6) also occurred, but no respiratory depression 
was observed. The incidence of pruritus was significantly lower 
in group S1 than in group S2 (P = 0.041), and lower in group S1 
than in group S3 (P = 0.003) (Table 2). There were no differences 
in the degree of satisfaction for PCEA (Table 3). 
Fig. 1. Changes in postoperative pain in visual analogue scale (VAS, 
cm). Values are median and range. All drugs were epidurally admini-
stered. ●: group F (0.1% ropivacaine 250 ml + fentanyl 4 μg/ml), ○: 
group S1 (0.1% ropivacaine 250 ml + sufentanil 0.5 μg/ml), ▼: group 
S2 (0.1% ropivacaine 250 ml + sufentanil 0.75 μg/ml), ▽: group S3 
(0.1% ropivacaine 250 ml + sufentanil 1.0 μg/ml). 
Table 1. Patient Demographics and Anesthetic Observations
Variables
Group F
(n = 20)
Group S1
(n = 17)
Group S2
(n = 17)
Group S3
(n = 17)
Age (yr)
Gender (M/F)
Weight (kg)
Height (cm)
Top (min)
Tanes (min)
ASA I
ASA II
ASA III
Blood loss (ml)
69.1 ± 7.2
  6/14
62.3 ± 10.9
154.5 ± 9.7
113.3 ± 24.3
191.0 ± 20.4
6
12
2
490 ± 155
69.7 ± 6.4
  4/13
57.6 ± 8.1
155.1 ± 8.2
100.0 ± 31.8
175.3 ± 35.4
6
11
0
582 ± 390
68.4 ± 5.9
   3/14
56.9 ± 7.8
155.1 ± 8.3
91.8 ± 17.3
177.1 ± 26.6
5
11
1
473 ± 75
66.9 ± 7.9
   4/13
60.2 ± 8.2
154.9 ± 10.0
117.4 ± 39.5
205.0 ± 46.7
3
13
1
523 ± 139
Values are mean ± SD or number of patients, Group F: 0.1% ropivacaine + fentanyl 4 μg/ml, Group S1: 0.1% ropivacaine + sufentanil 0.5 μg/
ml, Group S2: 0.1% ropivacaine + sufentanil 0.75 μg/ml, Group S3: 0.1% ropivacaine + sufentanil 1.0 μg/ml, Top: duration of operation, Tanes: 
duration of anesthesia, ASA: physical status classification of patients according to the American society of anesthesiologists, All drugs were 
epidurally administered.
Table 2. The Incidence of Recorded Side Effects 
Variables
Group F
(n = 20)
Group S1
(n = 17)
Group S2
(n = 17)
Group S3
(n = 17)
Nausea/Vomiting
Pruritus
Headache
Numbness
Sedation
Hypotension
Respiratory depression
7 (35%)
3 (15%)
5 (25%)
4 (20%)
0 (0%)
0 (0%)
0(0%)
4 (23.5%)
0 (0%)
2 (11.8%)
5 (29.4%)
3 (17.6%)
1 (5.9%)
0 (0%)
5 (29.4%)
  5 (29.4%)*
4 (23.5%)
2 (11.8%)
0 (0%)
0 (0%)
0 (0%)
7 (41.2%)
  7 (41.2%)*
2 (11.8%)
3 (17.6%)
3 (17.6%)
0 (0%)
0 (0%)
Values are number of patients (%). Group F: 0.1% ropivacaine + 
fentanyl 4 μg/ml, Group S1: 0.1% ropivacaine + sufentanil 0.5 μg/
ml, Group S2: 0.1% ropivacaine + sufentanil 0.75 μg/ml, Group S3: 
0.1% ropivacaine + sufentanil 1.0 μg/ml. All drugs were epidurally 
administered. *P < 0.05 compared with group S1.
Table 3. Patient Assessment of the Effectiveness of Pain Control
Variables
Group F
(n = 20)
Group S1
(n = 17)
Group S2
(n = 17)
Group S3
(n = 17)
Very good
Good
Fair
Poor
5 (25%)
10 (50%)
5 (25%)
0 (0%)
1 (5.9%)
13 (76.5%)
3 (17.6%)
0 (0%)
6 (35.3%)
10 (58.8%)
1 (5.9%)
0 (0%)
1 (5.9%)
13 (76.%)
3 (17.6%)
0 (0%)
Values are numbers of patients (%). Group F: 0.1% ropivacaine + 
fentanyl 4 μg/ml, Group S1: 0.1% ropivacaine + sufentanil 0.5 μg/
ml, Group S2: 0.1% ropivacaine + sufentanil 0.75 μg/ml, Group S3: 
0.1% ropivacaine + sufentanil 1.0 μg/ml. All drugs were epidurally 
administered.44 www.ekja.org
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Discussion
    After Hip or knee joint replacement arthroplasty, PCEA for 
relieving postoperative pain with ropivacaine, sufentanil and 
fentanyl were able to achieve satisfactory pain relief effects (VAS 
≤ 3). There were also no differences in the incidence of side 
effects and the degree of satisfaction. 
    In general, patients undergoing hip or knee replacement 
arthroplasty experienced severe pain after surgery. In addition, 
most patients were aged above 60 years (91.5%) in this study. 
In elderly patients, postoperative pain can cause or increase 
respiratory and cardiovascular complications. Therefore, careful 
pain management is critical. 
    PCEA reduces pathophysiological changes associated with 
surgery, induces faster recovery of gastrointestinal function, 
reduces myocardial ischemia and reduces respiratory 
complications in elderly patients. Each of these reasons 
improves the prognosis [10-12]. In addition, pain relief of PCEA 
is more effective than intravenous PCA and the requirement 
of opioids is reduced which results in a higher degree of satis-
faction [1]. 
    Among the local anesthetics in PCEA, ropivacaine has a 
similar onset time, duration and intensity of sensory nerve 
blocking as compared with bupivacaine. Otherwise, ropivacaine 
has lower central nervous system toxicity and cardiac toxicity 
and has shorter duration as well as lower intensity of motor 
blocking than bupivacaine [13,14]. The two drug's activity ratio 
is reported as 0.6 [15,16]. According to the given activity ratio 
(0.15% ropivacaine and 0.75% bupivacaine), sensory block 
is similar but in ropivacaine, the intensity is lower and the 
duration is shorter than in bupivacaine [17]. 
    Epidural infusion of local anesthetics alone results in higher 
drug dosage. Following that, early ambulation is difficult 
because the motor nerves are blocked and hemodynamic 
instability occurs due to sympathetic nerves being blocked 
[18,19]. Therefore, lowering the concentration of local 
anesthetics induces hemodynamic stability. This also prevents 
gait disorders caused by proprioceptor block and motor nerve 
block and prevents the pressure injury due to sensory nerve 
block [20]. However, the analgesic effect is also reduced [21,22]. 
Therefore, lowering the concentration of local anesthetics and 
combination of epidural opioids can reduce the side effects of 
local anesthetics and the analgesic effect can be magnified. 
    Lorenzini et al. [23] reported patients receiving knee surgery 
with epidural injection of 0.2% ropivacaine with added 
sufentanil 1.0 μg/ml to have a more effective analgesic effect 
than only 0.2% ropivacaine. Kampe et al. [24] reported patients 
receiving hip replacement arthroplasty with epidural injection 
of 0.1% ropivacaine with added sufentanil 1.0 μg/ml to have a 
reduction of postoperative use of analgesics without increasing 
the incidence of side effects by using only 0.1% ropivacaine. 
    Opioid-based techniques have been used widely. Clinically, 
epidurally administered lipophilic fentanyl and sufentanil are 
often used because these have a rapid onset of analgesic effects 
and are a good choice for pain relief. Hydrophilic morphine is 
also used in some cases [18,25]. Since fentanyl and sufentanil 
have higher affinity on dorsal horn opioid receptors than lipid 
insoluble morphine, they have faster and more potent analgesic 
effects. Also, the degree of rostral migration of the lipophilic 
fentanyl and sufentanil in the CSF is less than morphine. 
For these reasons, they have a low incidence of prolonged 
respiratory depression. But, a continuous infusion was required 
for postoperative analgesia because the duration of action was 
shorter [1,20]. 
    The lipid solubility of sufentanil was 1,000 folds higher than 
morphine and 8-10 folds higher than fentanyl. Sufentanil was 
more selective against the μ receptor antagonist than fentanyl 
and had a higher intensity than fentanyl or morphine. Also, 
the effect on the motor nerve was low, and 0.5-1.0 μg/ml 
sufentanil was co-administered with local anesthetics [1].
    In previous studies, the optimal concentration of ropivacaine 
when used for epidural analgesia is 0.1-0.2% [26,27] and 
fentanyl 4 μg/ml is often used for pain control [1,27]. We 
therefore used 0.1% ropivacaine and fentanyl 4 μg/ml in the 
control group. The treatment is considered effective when it 
decreases the VAS score below 30 mm clinically [28]. In this 
study, the treatment demonstrated adequate effects in all four 
groups.
    Postoperative nausea/vomiting (PONV) occurred due to 
many reasons and 20-30% patients experienced PONV after 
general anesthesia [29]. In addition, epidural infusion of local 
anesthetics can cause hypotension, and consequently cause 
nausea/vomiting. But in this study, only one patient experienced 
hypotension and this patient had no PONV. So, it was concluded 
that hypotension had no effect on nausea/vomiting. Intravenous 
or epidural opioid injections can increase the incidence of 
PONV. Statistical analyses revealed no meaningful differences 
between sufentanil groups but the incidences of PONV 
increased when the dose of sufentanil was raised. So, there is a 
possibility that sufentanil and general anesthesia might be risk 
factors of nausea and vomiting. However, to understand the 
exact effects further study is needed. Usually PONV subsided 
spontaneously or by intravenous ondansetron 4 mg. The 
incidences of pruritus were only significantly increased when 
the dose of sufentanil was raised but most symptoms were 
mild and subsided when PCEA stopped. Sedation occurred 1 
hour after surgery in 6 patients but this symptom disappeared 
spontaneously. Sedation showed in 6 patients within 1 hour 
after operation, which regressed without specific care. Sedation 
showed no significant difference within groups. 45 www.ekja.org
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    Numbness was associated with the concentrations of 
ropivacaine and the level of lumbar block. Choi et al. [30] 
reported that when patients received 0.15% ropivacaine with 
fentanyl 2 μg/ml for postoperative epidural analgesia at a rate 
of 5 ml/hr, there was no experience of numbness. Ahn et al. 
[27] reported that when patients received 0.2% ropivacaine 
with fentanyl 4 μg/ml at a rate of 2 ml/hr, 1 of 32 patients (3.2%) 
experienced varying degrees of numbness. In this study, the 
incidence of numbness is higher than in other studies. It is 
possible that numbness was confused with surgical pain or 
paresthesia and therefore not measured precisely. Thirteen 
cases of headache occurred but no dural punctures were 
observed. It was therefore concluded that headaches occurred 
due to inhalation anesthetics [31] and no patients complained 
of headache after or at the time of being discharged. The 
patients answered positively about satisfaction (very good, 
good) and there were 75% in group F, 82.4% in group S1, 94.1% 
in group S2 and 82.4% in group S3. No statistical differences 
were observed between these measurements. 
    A limitation of this study was the small sample size of each 
group. We therefore can not effectively detect the differences in 
the incidence of side effects. We calculated a sample size with 
the degree of pain scores in each group yet the sample size was 
not enough for the detection of rare side effects. 
    In this study, sufentanil and fentanyl for postoperative 
epidural analgesia seem to have the same analgesic effects 
and there are no differences in the incidence of side effects 
and the degree of satisfaction in each group, so sufentanil 
should replace fentanyl. Since there are no differences in the 
incidence of side effects and the postoperative pain score in 
each sufentanil group, we conclude that the smallest dose 
of sufentanil 0.5 μg/ml is enough for PCEA and believe that 
more studies on the smaller dose of sufentanil are needed for 
minimizing the incidence of side effects. 
    In conclusion, after hip or knee joint replacement, PCEA 
for relieving postoperative pain with ropivacaine, sufentanil 
and fentanyl were able to achieve a satisfactory pain relief 
effect (VAS ≤ 3). Using different doses of the sufentanil group, 
similar analgesic effects were observed. Therefore, sufentanil 
like fentanyl for PCEA can be used effectively and sufentanil 
0.5 μg/ml is enough for postoperative pain control and side 
effects. Consequently, we think sufentanil 0.5 μg/ml is the 
recommended dose for PCEA.
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